Bio-Reference Laboratories (BRLI) announced Thursday morning that it has agreed to be acquired by OPKO Health Inc. (OPK) for $52.58 per share, or approximately $1.47 billion.
Bio-Reference Laboratories gapped open dramatically higher Thursday, but then declined until around 1:30PM, before settling into a range. Shares still finished with a gain of 6.64 at $39.60, but were well off their early high of $46.74. The stock jumped to a new high for the year on the highest trading volume of the year.
For comments and feedback contact: editorial@rttnews.com
Business News